Literature DB >> 4070784

Metabolite concentrations in plasma following treatment of cattle with five anthelmintics.

R K Prichard, D R Hennessy, J W Steel, E Lacey.   

Abstract

Plasma concentrations of anthelmintics and their metabolites were determined after cattle were treated at recommended dose rates and routes of administration. Fenbendazole, oxfendazole, febantel, albendazole and thiabendazole were given orally and oxfendazole was also administered with an intraruminal injector. After fenbendazole, oxfendazole and febantel were administered, fenbendazole, oxfendazole and fenbendazole sulphone were all detected in plasma in each case. However, there were marked differences between the three anthelmintics in the peak concentrations and areas under the plasma concentration/time curve (AUC) of these three metabolites. Intraruminal administration of oxfendazole produced higher AUC for fenbendazole and fenbendazole sulphone than did oral administration. Albendazole sulphoxide and sulphone were detected in cattle plasma after albendazole administration but no parent drug was present. These metabolites disappeared more rapidly in cattle than has been reported for sheep. Only 5(6)hydroxythiabendazole was detected in cattle plasma after thiabendazole treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070784

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  10 in total

1.  Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.

Authors:  Laura Ceballos; Celina Elissondo; Sergio Sánchez Bruni; Guillermo Denegri; Carlos Lanusse; Luis Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  The pharmacokinetics and efficacy of long-term low-level and split-dose administration of albendazole through in-feed formulations against ovine and caprine parasitic gastroenteritis.

Authors:  P K Sanyal
Journal:  Vet Res Commun       Date:  1998-11       Impact factor: 2.459

3.  The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.

Authors:  P K Sanyal
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

4.  Pharmacokinetics and metabolism of fenbendazole in channel catfish.

Authors:  J V Kitzman; J H Holley; W G Huber; G D Koritz; L E Davis; C A Neff-Davis; R F Bevill; C R Short; S A Barker; L C Hsieh
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

5.  Effects of diet and species on the pharmacokinetics of fenbendazole in cattle.

Authors:  M R Knox; J W Steel
Journal:  Vet Res Commun       Date:  1997-01       Impact factor: 2.459

6.  Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines.

Authors:  S Rolin; H Souhaili-el Amri; A M Batt; M Levy; D Bagrel; G Siest
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

7.  Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-05-30       Impact factor: 2.289

8.  Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.

Authors:  A Goudah
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

9.  Comparative pharmacokinetics of fenbendazole in buffalo and cattle.

Authors:  M R Knox; P M Kennedy; D R Hennessy; J W Steel; L F Le Jambre
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

10.  Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers.

Authors:  Laura Ceballos; Alejandro Krolewiecki; Marisa Juárez; Laura Moreno; Fabian Schaer; Luis I Alvarez; Rubén Cimino; Judd Walson; Carlos E Lanusse
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.